BioRes

BioRes is a preclinical biotechnology company developing a platform for controlled, repeatable cellular rejuvenation.

The company's approach aims to restore cellular function as a way of addressing the underlying biological causes of age-related decline and disease, rather than treating individual conditions in isolation.

Designed as a platform rather than a single product, the work is progressing toward initial human cell validation milestones, alongside development of a defensible international intellectual property base.